Maritza Yesenia Estrada-o'brien, Family Medicine Medicare: Medicare Enrolled Practice Location: 1405 E 12th St Ste 600, Mendota, IL 61342 Phone: 815-538-7200 |
Amy Matheis-soliman, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 East 12th Street, Suite 600, Mendota, IL 61342 Phone: 815-538-7200 Fax: 815-539-1718 |
Leonardo Lopez, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1311 Memorial Dr Ste 500, Mendota, IL 61342 Phone: 815-539-3141 Fax: 815-487-4901 |
David A Scholl, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1405 East 12th Street, Suite 600, Mendota, IL 61342 Phone: 815-538-7200 Fax: 815-539-1444 |
Zachary J Fulton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1405 E 12th St Ste 200, Mendota, IL 61342 Phone: 815-539-1710 |
News Archive
New research holds promise for the thousands of people whose cancer has spread to their bones.A common treatment for such patients is radiation surgery even though very little is known about radiosurgery's impact on bone strength, says Edmond Richer, associate professor of engineering at Southern Methodist University in Dallas.
Researchers from Boston University School of Medicine determined that excess abdominal fat places otherwise healthy, middle-aged people at risk for dementia later in life. Preliminary findings suggest a relationship between obesity and dementia that could lead to promising prevention strategies in the future. Results of this study are published early online in Annals of Neurology, a journal of the American Neurological Association.
"More than 50 percent of all new cancers and two-thirds of the annual cancer mortality worldwide happen in low-income and middle-income countries," a Lancet editorial states and describes how the recently released report Closing the Cancer Divide, by the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, "presents a compelling case for comprehensive action on expanded access to cancer care and control with realistic recommendations that will be beneficial beyond cancer."
Johnson & Johnson and Micrus Endovascular Corporation, a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, today announced a definitive agreement whereby Micrus Endovascular will be acquired in a cash for stock exchange.
› Verified 5 days ago